| Followers | 144 |
| Posts | 28021 |
| Boards Moderated | 4 |
| Alias Born | 02/07/2004 |
Tuesday, August 25, 2009 12:16:19 PM
GenoMed in Discussions with Philippines Dept of Health to Eradicate Kidney Failure
FOR IMMEDIATE RELEASE
Contact:
David W. Moskowitz MD
CEO, GenoMed
Tel. 314.983.9938
dwmoskowitz@genomed.com
ST. LOUIS—August 25, 2009—GenoMed® (OTC Pink Sheets GMED.PK), the Public Health Company™, announced today that it has entered into discussions with the Department of Health of the Philippines to eliminate 95% of kidney failure from that country.
This follows on GenoMed's earlier memorandum of understanding with LaSalTech, a call center in Bacolod, Republic of the Philippines (RP). GenoMed will teach LaSalTech physicians its "recipe" and they, in turn, will recommend it to the 20 million adults with high blood pressure in the RP. An electronic record will be created for each patient, and GenoMed will supervise the operation from its St. Louis headquarters.
GenoMed and LaSalTech are also in discussions with a chain of retail pharmacies which would serve as the point of contact with the country's 20 million hypertensive patients.
Said Dr. Moskowitz, GenoMed's CEO, "We're delighted that the Department of Health of the Philippines is interested in supporting us. Their involvement is crucial."
Dr. Moskowitz continued, "If we succeed at a state-of-the-art, prevention-based healthcare solution for even the poorest Filipino, we will be able to export it to other countries, especially the US. President Obama has called for just such a solution. Unfortunately, Medicare has had no interest whatsoever in cutting 10% of its budget, or $35 billion a year."
Dr. Moskowitz ended by saying, "The Philippine government, on the other hand, simply can't afford to dialyze 20,000 new patients each year, and is committed to prevention. Our partner, LaSalTech, and Brother Rolando Dizon, its Chairman, helped make this happen. This is a great day for GenoMed's shareholders. We finally get a chance to show our stuff in a nation of 90 million."
About LaSalTech (www.lasaltech.com)
LaSalTech was the first Internet service provider in Bacolod, a city of 750,000 in Negros Occidental, the sugar-growing province of the Philippine Islands. Several years ago, LaSalTech entered the growing business of Call Centers. Brother Rolando Dizon, its Chairman, has been a trusted advisor to Philippine Presidents. He helped Cory Aquino overthrow former President Ferdinand Marcos.
About GenoMed (www.genomed.com)
GenoMed is a Next Generation Disease Management company that aims to deliver the best patient outcomes at the lowest possible cost. GenoMed wants to prove that it can arrest diabetes, hypertension, and emphysema even in a developing country with scant resources like the Philippines. GenoMed intends to be the global healthcare provider of choice, especially for America's 50 million uninsured.
FOR IMMEDIATE RELEASE
Contact:
David W. Moskowitz MD
CEO, GenoMed
Tel. 314.983.9938
dwmoskowitz@genomed.com
ST. LOUIS—August 25, 2009—GenoMed® (OTC Pink Sheets GMED.PK), the Public Health Company™, announced today that it has entered into discussions with the Department of Health of the Philippines to eliminate 95% of kidney failure from that country.
This follows on GenoMed's earlier memorandum of understanding with LaSalTech, a call center in Bacolod, Republic of the Philippines (RP). GenoMed will teach LaSalTech physicians its "recipe" and they, in turn, will recommend it to the 20 million adults with high blood pressure in the RP. An electronic record will be created for each patient, and GenoMed will supervise the operation from its St. Louis headquarters.
GenoMed and LaSalTech are also in discussions with a chain of retail pharmacies which would serve as the point of contact with the country's 20 million hypertensive patients.
Said Dr. Moskowitz, GenoMed's CEO, "We're delighted that the Department of Health of the Philippines is interested in supporting us. Their involvement is crucial."
Dr. Moskowitz continued, "If we succeed at a state-of-the-art, prevention-based healthcare solution for even the poorest Filipino, we will be able to export it to other countries, especially the US. President Obama has called for just such a solution. Unfortunately, Medicare has had no interest whatsoever in cutting 10% of its budget, or $35 billion a year."
Dr. Moskowitz ended by saying, "The Philippine government, on the other hand, simply can't afford to dialyze 20,000 new patients each year, and is committed to prevention. Our partner, LaSalTech, and Brother Rolando Dizon, its Chairman, helped make this happen. This is a great day for GenoMed's shareholders. We finally get a chance to show our stuff in a nation of 90 million."
About LaSalTech (www.lasaltech.com)
LaSalTech was the first Internet service provider in Bacolod, a city of 750,000 in Negros Occidental, the sugar-growing province of the Philippine Islands. Several years ago, LaSalTech entered the growing business of Call Centers. Brother Rolando Dizon, its Chairman, has been a trusted advisor to Philippine Presidents. He helped Cory Aquino overthrow former President Ferdinand Marcos.
About GenoMed (www.genomed.com)
GenoMed is a Next Generation Disease Management company that aims to deliver the best patient outcomes at the lowest possible cost. GenoMed wants to prove that it can arrest diabetes, hypertension, and emphysema even in a developing country with scant resources like the Philippines. GenoMed intends to be the global healthcare provider of choice, especially for America's 50 million uninsured.
Recent GMED News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 09:03:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:20:59 PM
- Globus Medical Reports First Quarter 2026 Results • GlobeNewswire Inc. • 05/07/2026 08:15:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/30/2026 02:33:57 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/24/2026 08:06:06 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/24/2026 08:04:33 PM
- Globus Medical Schedules First Quarter Earnings Release and Conference Call • GlobeNewswire Inc. • 04/16/2026 08:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/14/2026 07:34:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 09:26:25 PM
- Globus Medical Announces Board Departure • GlobeNewswire Inc. • 03/23/2026 09:25:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 10:53:36 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/25/2026 08:41:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/24/2026 10:08:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/24/2026 09:23:38 PM
- Globus Medical Reports Fourth Quarter and Full Year 2025 Results • GlobeNewswire Inc. • 02/24/2026 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 10:22:37 PM
- Globus Medical Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call • GlobeNewswire Inc. • 02/12/2026 09:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/12/2026 05:12:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2026 10:10:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2026 10:05:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2026 10:03:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2026 10:01:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2026 09:59:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2026 09:56:45 PM
